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Abstract
Background: The promotion of care pathways in the recent Governmental health policy reports of Lord Darzi is likely 
to increase efforts to promote the use of care pathways in the NHS. Evidence on the process of pathway 
implementation, however, is sparse and variations in how organisations go about the implementation process are 
likely to be large. This paper summarises what is known about factors which help or hinder clinicians in adopting and 
putting care pathways into practice, and which consequently promote or hinder the implementation of scientific 
evidence in clinical practice.
Discussion: Care pathways can provide patients with clear expectations of their care, provide a means of measuring 
patient's progress, promote teamwork on a multi-disciplinary team, facilitate the use of guidelines, and may act as a 
basis for a payment system. In order to achieve adequate implementation, however, facilitators and barriers must be 
considered, planned for, and incorporated directly into the pathway with full engagement among clinical and 
management staff. Barriers and/or facilitators may be present at each stage of development, implementation and 
evaluation; and, barriers at any stage can impede successful implementation. Important considerations to be made are 
ensuring the inclusion of all types of staff, plans for evaluating and incorporating continuous improvements, allowing 
for organisational adaptations and promoting the use of multifaceted interventions.
Summary: Although there is a dearth of information regarding the successful implementation of care pathways, 
evidence is available which may be applied when implementing a care pathway. Multifaceted interventions which 
incorporate all staff and facilitate organisational adaptations must be seriously considered and incorporated alongside 
care pathways in a continuous manner. In order to better understand the mechanism upon which care pathways are 
effective, however, more research specifically addressing conditions under which providers become engaged in using 
care pathways is needed.
Background
Care pathways may serve as useful and evidence-based
tools to reduce variations in clinical practice and improve
quality and outcomes of healthcare interventions. Care
pathway implementation is likely to become increasingly
emphasised in England given its prominence within the
recent Governmental health policy reports of Lord Darzi
[1,2]. Care pathways are cited by Darzi as a form of qual-
ity improvement to be implemented in the NHS, and
indeed pathway development has already begun for
selected health conditions in all regions of the country
[1,2].
Although definitions of what care pathways entail vary
somewhat, two components consistently play a role: (a)
the types of services/interventions provided; and (b) the
timeline over which these happen [3]. Although several
terms have been used largely synonymously (including
clinical pathways and clinical care pathways) to refer to
this concept, in this paper we shall refer to care pathways
[4].
The care pathway concept
This paper reviews the evidence on whether care path-
ways may ameliorate weaknesses in the implementation
of guidelines and protocols by more specifically engaging
with the clinical team at each stage of pathway develop-
ment. In particular we aim to identify which factors facil-
itate or present barriers to care pathway implementation.
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Such care pathways incorporate clinical guidelines in that
the latter are embedded into the pathway itself. Although
clinical guidelines are usually developed in a top-down
fashion, care pathways are more often derived from the
bottom-up, so that the pathway precisely fits the configu-
ration of the local heath service. Such pathways may
adapt to nuances between institutional cultures by
including teams of clinical service providers and manag-
ers in their local creation and implementation. Moreover,
the process of creating a pathway calls for individuals
from all sectors to be involved in defining their own roles,
in terms of responsibilities and relationship to others in
the local 'healthcare economy'. Consequently, there
should be a sense of participation in pathway design but
also accountability in terms of implementation.
Discussion
Engagement in developing care pathways
Successful implementation of care pathways, to a large
extent, depends on the involvement and investment of
both clinical service providers and managers[5]. Engage-
ment of all relevant staff is necessary to ensure proposed
aims are achieved, at each stage from pathway adoption,
implementation and maintenance. Although interest in
care pathways has recently and rapidly increased within
the NHS [1,2], it is important to appreciate that the evi-
dence base on pathway creation greatly exceeds what is
known on how to engage providers and how to modify
their practice [6]. Several studies suggest that simply pro-
viding information alone does not impact evidence-based
practice [7-9]. Many healthcare institutions make such
initiatives without significant clinician engagement [10].
The proposed NHS Constitution in England [11] pledges
to address this by striving to "engage staff in decisions
that affect them and the services they provide." Conse-
quently, building and applying the evidence on clinical
engagement will be significant toward achieving success-
ful implementation of pathways.
The specific intent of involving a range of providers in
the pathway process, is significant, but is still subject to
barriers which occur in guideline implementation and
therefore insufficient to ensure clinical engagement. As
the literature on implementing care pathways is sparse,
this paper also draws on lessons from clinical guidelines
and protocols, as they have received more scrutiny, espe-
cially examining active implementation efforts rather
than passive diffusion [12-14]. Specifically, we carried out
a search on the databases of CINAHL 1982-2007,
EMBASE 1980-2007, Ovid MEDLINE 1996-2007, 
Journals@Ovid
 Full Text June 2006, EBM CCTR, CDSR, DARE, ACP
Journal Club, all 2nd quarter 2007, using the search terms
clinical, care, critical, integrated in combination with
pathway/s; also guidelines, protocol, implementation,
evaluation, facilitate$, barriers combined with the former
search terms. Inclusion criteria for this review were Eng-
lish speaking peer reviewed articles focusing on evaluated
or synthesised interventions used to implement guide-
lines, protocols or pathways at a system level. Two
researchers (SEL and MJ) coded facilitators and barriers
discerned from the literature. We do not report the
results from all articles; however this reviewing strategy
ensured saturation of all types of facilitators and barriers
reported in the literature. Based on this review, we
address potential barriers which may impede implemen-
tation and suggest interventions which may increase the
uptake and usage of care pathways.
Barriers to clinical engagement
Barriers which impede clinical engagement and uptake of
care pathways may occur at the staff (clinician or man-
agement) or healthcare organisation (management,
resources, and financial or institutional structures) level
or be influenced by external factors (broader health and
social policies or patient characteristics) [2,5,13,15-17].
Most literature, however, focuses on clinician-related
barriers. This evidence is shown in Figure 1, which illus-
trates both facilitators and barriers in the design, imple-
mentation and evaluation of care pathways.
A review by Cabana et al. [18], categorised barriers as
those which relate to clinician knowledge, attitudes, and
behaviours. Knowledge-related barriers stem from lack of
awareness and familiarity [18]. Studies have demon-
strated knowledge gaps among clinicians in following the
publication of guidelines [19] though modifying docu-
mentation or wording may make them more user-friendly
[20,21]. Cabana notes attitude-related barriers, including
general guideline disagreement, lack of applicability to
certain clinicians, conflicting information among differ-
ent sets of guidelines, lack of outcome expectancy, and
inertia of previous practice [18]. Additional attitude-
related barriers may result from clinicians being uncon-
vinced of the rationale for pathway implementation. For
instance, pathways may be perceived to be driven by rea-
sons relating to management or cost containment rather
than as decision-supporting tools [22].
Clinicians may have mixed or negative attitudes regard-
ing standardisation of healthcare through the use of path-
ways. For example, Jones notes that providers feel care
pathways might compromise the "artistic aspect of prac-
tice" [23]. Even though clinicians may appreciate the
guidance and information that pathways can provide,
they may also feel that pathways are externally imposed
and threaten clinical autonomy by being overly prescrip-
tive and leading to additional work [18,22]. For example,
the criticism that pathways are excessively prescriptive
may be countered by the assumption that the develop-
ment of healthcare tariffs, such as the Payment by ResultsEvans-Lacko et al. BMC Health Services Research 2010, 10:182
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system in England (PBR), requires some standardisation
of care. For PBR to work, the tariff paid must relate to
care packages that will not vary greatly between provid-
ers.
Support for care pathways may also differ by type of
provider. Some studies suggest nursing staff view path-
ways more negatively than physicians. This may be
explained, in part, by use of language which is perceived
as "medicalised" and by excluding nurses or other profes-
sionals in pathway development [24]. Staff having more
involvement may attach greater value to incorporating
recommended practices into their behaviour, while clini-
cians who were not involved may perceive pathways as
burdensome or detrimental to patient care, making them
reluctant to adhere to the pathway as it was designed [25].
Consequently, care pathways may contribute to providers
deliberately 'gaming', for example, to miscode a patient's
diagnosis in order to facilitate specific interventions for
particular patients [26], possibly due to beliefs that a cer-
tain treatment will not be effective due to a patient's
inability or opposition to follow through with certain
treatments, goals of obtaining higher reimbursement (so
called 'cream-skimming'), or reluctance to put a patient
into a specified pathway group. Providers may also be
concerned that comparing the actual care delivered with
a care pathway makes them more susceptible to litigation
should the patient suffer harm during the course of treat-
ment [27].
Although responsibility for guideline adherence often
focuses on clinicians, factors external to the clinician may
present significant barriers to engagement. Types of
organisational or external barriers noted in the literature
include time constraints, available resources/facilities,
insufficient staff, staff turnover, variation in implementa-
tion across teams, poor reimbursement, lack of training
in the use of pathways, increased costs (practice and lia-
bility) and patient characteristics [18,28]. A survey of 17
European countries, for example, found that the influence
of external bodies (such as purchasers), lack of encour-
agement and financial support for pathway development,
and payment incentives to be the most commonly
reported organisational or external constraint to pathway
implementation [29]. Less malleable factors, however,
such as patient characteristics may also play a role; cer-
tain patients may be better informed, or exert their pref-
erences for certain treatments which may or may not be
recommended [30].
Interventions to improve clinical engagement
No one implementation strategy can be expected to be
successful in all contexts, and the literature suggests a
multifaceted intervention which is setting-specific is
most likely to be effective [18] Since barriers occur at sev-
eral levels, interventions which do not focus solely on the
clinician are more effective. Therefore, selecting an inter-
vention, requires consideration of both context and per-
sons for which it will be applied [5,31]. This may include
clinical and management staff and may occur at the Trust
(provider organisation) or unit level. Greenhalgh noted
seven key areas of consideration which must be evaluated
separately for each organisation when introducing any
type of systemic change(1) characteristics of the innova-
tion itself, (2) characteristics of the individuals targeted to
Figure 1 Stages in the Development of Evidence-Based Care Pathways (CPs).
NB.Figure 1 illustrates facilitators and barriers at each stage of the development of a care pathway. Barriers at any stage can stop successful implementation, 
The numbers shown indicate the relevant references. 
Failed Care 
Pathway 
Implementation
Successful Care 
Pathway 
Implementation
Facilitators
Barriers
Design 
 
Clinical and management staff 
involvement 3,11 
Clear language 9,12 
Context-specific 7,8 
Intervention specifically allows 
for measurable outcomes 3 
 
 
 
 
 
Lack of staff involvement 5, 7-9 
Lack of awareness/familiarity 18 
Lack of applicability to certain 
clinicians 20 
Conflicting information 18 
Mixed attitudes regarding 
standardization of care/artistic 
aspect of practice 23 
Medicalised language alienating 
other disciplines 24 
Time constraints 18, 28 
Available resources/facilities 18, 
28 
Insufficient staff 18, 28 
Increased cost 18, 28 
Implementation 
 
Support from management and clinical 
staff involvement 3,11 
Provide reimbursement /financial 
incentive s 17,18 
Allow for flexibility 12,17 
Staff training 3, 7, 17 
 
Lack of outcome expectancy 18 
Inertia of previous practice 18 
Unconvinced of rationale for pathway 
implementation 22 
Overly prescriptive and leading to 
additional work/rigidity 18, 22 
Active resistance due to lack of 
involvement at design level/ belief that 
CPs are detrimental to patient care 25 
‘Gaming the system’ 26 
Susceptibility to litigation: gap between 
actual care delivered and care 
pathway 27 
Time Constraints 18, 28 
Available resources/facilities 13 
Insufficient staff 13 
Staff turnover 18, 28 
Poor reimbursement 18, 28 
Lack of training in the use of pathways 
18, 28 
Evaluation 
Clinical and management staff 
involvement and support 3 
Monitor impact of potential 
barriers occurring at design or 
implementation stage 4,7 
Examine need for system or 
organisation level changes 8 
Include process and outcome 
measures 3,12 
 
 
 
Time constraints 18, 28 
Available resources/facilities 
Staff turnover 18, 28 
Lack of evaluation 5 
Lack of feedback 5 
Lack of staff involvement 5, 42, 
42 
Support from all levels 13 Evans-Lacko et al. BMC Health Services Research 2010, 10:182
http://www.biomedcentral.com/1472-6963/10/182
Page 4 of 6
adopt it, (3) sources of communication and influence
regarding the innovation, (4) structural and cultural char-
acteristics of targeted organisations (5) external influ-
ences on targeted individuals or organisations, (6)
organisations' uptake processes, and (7) the inter-linkages
among these six factors [13].
Organisational culture and characteristics provide con-
text for understanding and choosing the most effective
mechanism of change [16]. There are, however, several
options of interventions which might be tailored to medi-
cal care settings. Grimshaw et al., identified six types of
published interventions: broad strategies, dissemination
and implementation of guidelines, programs to enhance
the quality and economy of primary care, interventions to
improve doctor-nurse collaboration, targeting of specific
behaviours, and focusing on the effectiveness of specific
interventions [6]. Rather than advocating a specific inter-
vention, Grimshaw et al., concluded that effectiveness
depends on context and, in general, passive approaches
are unlikely to affect behaviour [6]. A review of quality
improvement interventions supported this showing that
no intervention seemed to be associated with large
improvement and only multifaceted interventions were
associated with even moderate levels of improvement
[17].
Evaluations of specific types of interventions showed a
wide range of effectiveness, suggesting again that the con-
text and implementation process may be as important as
the intervention itself [32]. Therefore, although active,
multiple and co-ordinated interventions may be costly,
there is evidence that they are often more effective too. In
an examination of failed interventions, a combination of
"continued reliance on passive diffusion", disagreement
regarding guideline content, provider characteristics, and
logistic or financial barriers were hypothesised as the rea-
sons most often explaining failure to change behaviour
[17]. Methodological evaluation, however, may also be
complicated by lack of information regarding baseline
adherence [18], and different combinations of interven-
tions.
Although the literature emphasises a multi-faceted
approach, strengths and weaknesses of specific interven-
tions have also been analysed. One common intervention
used to change provider behaviour is Continuing Medical
Education (CME). Though traditional CME didactic lec-
tures and conferences have been shown to be ineffective
at changing behaviour, use of several targeted and
sequenced activities may have a positive impact [33-36].
Still, little is known about the most effective way to
implement training programs for providers [35]. More-
over, it seems that, as with many interventions, more
effective methods are often relatively costly and are rarely
implemented [6].
Decision aid tools have been tested as a way to improve
provider knowledge and streamline provider behaviour.
Overall, most trials show improved provider perfor-
mance in a variety of settings, though information
regarding patient outcomes is lacking [37,38]. An RCT of
decision support for treatment of depression vs. usual
care found process of care (e.g., ongoing specialty care
and psychotropic treatment) and patient satisfaction
improved, although clinical outcomes did not [39].
Change in provider behaviour may require system level
change. Although some organisational factors are less
malleable than others, (e.g., resource availability), more
flexible considerations such as staff restructuring might
be implemented to accommodate care pathways [40].
Current care processes should also be evaluated in terms
of their consistency with the implemented pathway and
ongoing feedback from staff should inform where sys-
temic barriers lie. Finally, alignment of payment with
interventions may improve uptake and subsequent prac-
tice [35], in order to act as an incentive for providers to
'comply' with care pathways that have determined the tar-
iff used in commissioning services. Financial incentives
have previously been shown to be useful ways of encour-
aging change, for example in relation to GPs achieving
Quality and Outcomes Framework targets such as assess-
ing levels of depression among their caseload41.
Conclusion
Care pathways may have merit in terms of their potential
to improve healthcare practice3. They can focus
resources, provide a clear understanding for patients of
w h a t  t h e y  s h o u l d  e x p e c t  i n  t h e i r  c a r e ,  a n d  p r o v i d e  a
means of measuring patient's progress. They promote
teamwork via increased understanding of roles on a
multi-disciplinary team, and facilitate the use of guide-
lines in clinical practice in a usable format [20,41]. Fur-
thermore, they may act as a basis for a prospective
payment system, such as PBR. In order to achieve ade-
quate implementation, however, serious consideration of
potential barriers and specific locally agreed upon inter-
ventions to ensure effective implementation must be
planned for and incorporated directly with the pathway.
As with any quality improvement intervention, imple-
mentation and evaluation are a continuous process. This
process needs to involve all those taking part in the pro-
tocol and following identification and dissemination,
there must be decision support available, evaluation of
the application, and finally incorporation of results into
ongoing quality improvement [5,41,42]. Successful imple-
mentation of care pathways is dependent on the develop-
ment process. A lack of understanding about their role
and use by any staff group will doom them to failure [41].
In order to better understand the mechanism upon which
care pathways are effective, more research specificallyEvans-Lacko et al. BMC Health Services Research 2010, 10:182
http://www.biomedcentral.com/1472-6963/10/182
Page 5 of 6
addressing conditions under which providers become
engaged in using care pathways is needed.
Summary
• The promotion of care pathways in the Darzi 
reports is likely to increase efforts to promote the use 
of care pathways in the NHS.
• Inclusion and accountability of both clinical and 
management staff (at both junior and senior levels) in 
pathway development and implementation is neces-
sary for the successful uptake of care pathways.
• Evidence on the process of pathway implementation 
is sparse and variations in how organisations go about 
the implementation process are likely to be large.
• Multifaceted interventions which involve changing 
provider behaviour in addition to organisational 
adaptations must be seriously considered and incor-
porated alongside care pathways in a continuous 
manner.
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